<VariationArchive VariationID="39627" VariationName="NM_001170629.2(CHD8):c.2240dup (p.Tyr747Ter)" VariationType="Duplication" Accession="VCV000039627" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2013-04-04" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="48226" VariationID="39627">
      <GeneList>
        <Gene Symbol="CHD8" FullName="chromodomain helicase DNA binding protein 8" GeneID="57680" HGNC_ID="HGNC:20153" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="21385199" stop="21456123" display_start="21385199" display_stop="21456123" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="21853352" stop="21905456" display_start="21853352" display_stop="21905456" Strand="-" />
          </Location>
          <OMIM>610528</OMIM>
          <Haploinsufficiency last_evaluated="2018-04-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD8">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-04-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD8">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001170629.2(CHD8):c.2240dup (p.Tyr747Ter)</Name>
      <CanonicalSPDI>NC_000014.9:21409974:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>14q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="21409974" stop="21409975" display_start="21409974" display_stop="21409975" variantLength="1" positionVCF="21409974" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="21878133" stop="21878134" display_start="21878133" display_stop="21878134" variantLength="1" positionVCF="21878133" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <OtherNameList>
        <Name>1-BP INS, T</Name>
      </OtherNameList>
      <ProteinChange>Y468*</ProteinChange>
      <ProteinChange>Y747*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.21878134dup" Assembly="GRCh37">
            <Expression>NC_000014.8:g.21878134dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.21409975dup" Assembly="GRCh38">
            <Expression>NC_000014.9:g.21409975dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021249.1" sequenceAccession="NG_021249" sequenceVersion="1" change="g.32324dup">
            <Expression>NG_021249.1:g.32324dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001170629.2" sequenceAccession="NM_001170629" sequenceVersion="2" change="c.2240dup" MANESelect="true">
            <Expression>NM_001170629.2:c.2240dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001164100.1" sequenceAccession="NP_001164100" sequenceVersion="1" change="p.Tyr747Ter">
            <Expression>NP_001164100.1:p.Tyr747Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020920.4" sequenceAccession="NM_020920" sequenceVersion="4" change="c.1403dup">
            <Expression>NM_020920.4:c.1403dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065971.2" sequenceAccession="NP_065971" sequenceVersion="2" change="p.Tyr468Ter">
            <Expression>NP_065971.2:p.Tyr468Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="610528.0002" DB="OMIM" />
        <XRef Type="rs" ID="2139484859" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001170629.2(CHD8):c.2240dup (p.Tyr747Ter) AND Intellectual developmental disorder with autism and macrocephaly" Accession="RCV000032827" Version="5">
        <ClassifiedConditionList TraitSetID="9184">
          <ClassifiedCondition DB="MedGen" ID="C3554373">Intellectual developmental disorder with autism and macrocephaly</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-12-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2024-06-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23160955</ID>
        </Citation>
        <DescriptionHistory Dated="2024-06-06">
          <Description>risk factor</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9184" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17563" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Autism, susceptibility to, 18</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual developmental disorder with autism and macrocephaly</ElementValue>
                <XRef ID="MONDO:0014017" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IDDAM</ElementValue>
                <XRef Type="MIM" ID="615032" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CHD8-related neurodevelopmental disorder with overgrowth (CHD8-NDD) is characterized by generalized overgrowth, developmental delayÂ / intellectual disability (DD/ID), autism spectrum disorder (ASD), neuropsychiatric issues, neurologic problems, sleep disturbance, and gastrointestinal issues The most common findings are the development of macrocephaly (most often during infancy) and tall stature (most typically during puberty), which is often accompanied by ASD and/or DD/ID. Most, if not all, affected individuals have some degree of DD, most commonly speech and motor delays. When present, ID is most often in the mild-to-moderate range. Sleep disturbance is characterized by difficulty with both initiation (delayed sleep onset) and maintenance (frequent night awakenings) of sleep. The most common gastrointestinal issue is constipation with or without periods of diarrhea. Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare).</Attribute>
                <XRef ID="NBK585456" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36302072</ID>
                <ID Source="BookShelf">NBK585456</ID>
              </Citation>
              <XRef ID="642675" DB="Orphanet" />
              <XRef ID="C3554373" DB="MedGen" />
              <XRef ID="MONDO:0014017" DB="MONDO" />
              <XRef Type="MIM" ID="615032" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="93793" SubmissionDate="2021-07-06" DateLastUpdated="2024-06-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="610528.0002_INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND MACROCEPHALY" title="CHD8, 1-BP INS, T_INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND MACROCEPHALY" />
        <ClinVarAccession Accession="SCV000056596" DateUpdated="2024-06-09" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-12-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 67-month-old non-Hispanic white male with intellectual developmental disorder with autism and macrocephaly (IDDAM; 615032), O'Roak et al. (2012) detected a heterozygous de novo 1-basepair insertion in the CHD8 gene that resulted in premature termination of the protein (tyr747 to ter; Y747X). The proband was nonverbal with extremely low verbal IQ of 25, nonverbal IQ of 38, and adaptive score of 57. His head circumference was 55 cm (z score = 2.0). He was diagnosed with cerebral palsy and was excessively clumsy and uncoordinated at 18 months. MRI/CT at 18 months was normal; EEG was normal at 24 months. The proband had a healthy 4-year-old sister.</Attribute>
              <Citation>
                <ID Source="PubMed">23160955</ID>
              </Citation>
              <XRef DB="OMIM" ID="615032" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHD8" />
          </GeneList>
          <Name>CHD8, 1-BP INS, T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610528.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND MACROCEPHALY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="93793" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND MACROCEPHALY" MappingRef="Preferred">
        <MedGen CUI="C3554373" Name="Intellectual developmental disorder with autism and macrocephaly" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

